Renal Cancer - Results from #5160

The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis June 1, 2017

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study. May 31, 2017

Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass May 31, 2017

Pazopanib for the Treatment of Non-Clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study May 31, 2017

A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer. May 31, 2017

A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805]). May 31, 2017

Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy May 29, 2017

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma May 26, 2017

The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study May 26, 2017

Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre. May 26, 2017

Incorporating New Systemic Therapies in Kidney Cancer Treatment May 25, 2017

Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers May 25, 2017

Prognostic Value of Vascular Endothelial Growth Factor A in the Prediction of the Tumor Aggressiveness in Clear Cell Renal Cell Carcinoma May 25, 2017

Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma May 23, 2017

First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience May 23, 2017

Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors May 22, 2017

Analysis of healthy and tumour DNA methylation distributions in kidney-renal-clear-cell-carcinoma using Kullback-Leibler and Jensen-Shannon distance measures May 22, 2017

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors May 12, 2017

Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau May 11, 2017

Risk models for patients with localised renal cell carcinoma May 11, 2017

Page 259 of 456